Legal & General Group’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
JT
PA
BBA
OAG
Legal & General Group's PRAX Position: Q2 2026 in Review
Legal & General Group increased its Praxis Precision Medicines (PRAX) stake by 3% in Q2 2026, buying an estimated $173K and bringing the position to 19,030 shares worth $6.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1451.
Legal & General Group first reported a position in PRAX in Q4 2020 and has held it in 19 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Legal & General Group held 19,030 shares of Praxis Precision Medicines worth $6.37M as of Q2 2026.
- Legal & General Group bought 548 Praxis Precision Medicines shares in Q2 2026, an estimated $173K.
- Praxis Precision Medicines made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1451 holding.
- Legal & General Group first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 19 quarters since.
- 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.